Walgreens Boots Alliance, Inc. - Common Stock (WBA)
10.34
-1.13 (-9.82%)
Walgreens Boots Alliance is a global healthcare leader that operates a chain of pharmacies, drugstores, and health and wellness retail outlets
The company is known for providing accessible pharmaceutical services and a wide range of health and beauty products. With a commitment to enhancing the health and well-being of its customers, Walgreens Boots Alliance focuses on delivering innovative healthcare solutions, including pharmacy services, immunizations, and health consultations. Additionally, the company engages in retail pharmacy and wholesale distribution, partnering with various healthcare providers to improve patient outcomes and ensure the availability of essential medications and healthcare products.
Walgreens Boots Alliance Suspends Quarterly Dividend as Company Continues Disciplined Execution Against Strategic Priorities
Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that its board of directors is suspending the company’s cash dividend historically paid to stockholders on a quarterly basis, as management continues to evaluate and refine its capital allocation policy consistent with the company’s broader long-term turnaround efforts.
By Walgreens Boots Alliance · Via Business Wire · January 30, 2025
Hanley Investment Group Arranges Sale of New Construction 9,000 SF Multi-Tenant Pad at Anatolia Marketplace in Rancho Cordova, Calif., for $6.08 Million
RANCHO CORDOVA, Calif. - Hanley Investment Group Real Estate Advisors, a nationally recognized real estate brokerage and advisory firm specializing in retail property sales, announced today that the firm arranged the sale of a new construction, 9,000-square-foot multi-tenant retail pad, Shops II, at the new Anatolia Marketplace shopping center in Rancho Cordova, California, an affluent suburb in the Sacramento metro area. The sale price was $6.08 million.
Via AB Newswire · January 28, 2025
Walgreens Announcement: If You Have Suffered Losses in Walgreens Boots Alliance, Inc. (NASDAQ: WBA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · January 28, 2025
Walgreens Investor News: If You Have Suffered Losses in Walgreens Boots Alliance, Inc. (NASDAQ: WBA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, Jan. 25, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · January 25, 2025
Walgreens Investor News: If You Have Suffered Losses in Walgreens Boots Alliance, Inc. (NASDAQ: WBA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · January 22, 2025
Walgreens Announcement: If You Have Suffered Losses in Walgreens Boots Alliance, Inc. (NASDAQ: WBA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, Jan. 19, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · January 19, 2025
Rosen Law Firm Encourages Walgreens Boots Alliance, Inc. Investors to Inquire About Securities Class Action Investigation – WBA
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Walgreens Boots Alliance, Inc. (NASDAQWBA) resulting from allegations that Walgreens may have issued materially misleading business information to the investing public.
By The Rosen Law Firm, P.A. · Via Business Wire · January 17, 2025
INVESTIGATION ALERT (NASDAQ: WBA): DiCello Levitt LLP Is Investigating Investor Claims Against Walgreens Boots Alliance, Inc. and Encourages WBA Investors with Losses to Contact the Firm
SAN DIEGO, Jan. 17, 2025 (GLOBE NEWSWIRE) -- DiCello Levitt LLP announces that it is investigating whether Walgreens Boots Alliance, Inc. (“Walgreens” or the “Company”) (NASDAQWBA) violated the federal securities laws, issued false and/or misleading statements, and/or failed to disclose information required to be disclosed to investors.
By DiCello Levitt LLP · Via GlobeNewswire · January 17, 2025
Walgreens Boots Alliance Reports Fiscal 2025 First Quarter Results
Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced financial results for the first quarter of fiscal 2025, which ended November 30, 2024.
By Walgreens Boots Alliance · Via Business Wire · January 10, 2025
Walgreens Boots Alliance Adjusts Fiscal 2025 First Quarter Earnings Announcement to be Held on January 10
Walgreens Boots Alliance, Inc. (Nasdaq: WBA) will release its fiscal year 2025 first quarter results at 7 a.m. ET on Friday, January 10, followed by a one-hour conference call with WBA management beginning at 8:30 a.m. ET.
By Walgreens Boots Alliance · Via Business Wire · January 2, 2025
The Boulder Group Arranges Sale of Net Leased Goodwill in the West Palm Beach MSA
The Boulder Group, a net leased investment brokerage firm completed the sale of a single tenant Goodwill located at 3535 9th Street Southwest in Vero Beach, Florida for $5,030,000.
Via AB Newswire · December 17, 2024
Walgreens Launches Inaugural Patient Advisory Board to Advance Access and Representation in Clinical Research
With a history of more than 120 years serving communities across the country, Walgreens prides itself in being a trusted retail pharmacy partner for more than 9 million patients and customers it serves each day. Walgreens is amplifying its commitment to its patients and partners through the formation of the Walgreens Clinical Trials Patient Advisory Board. Since its launch in June 2022, the Walgreens Clinical Trials team has reached more than 7 million patients to potentially recruit into sponsor-led clinical trials. As the team continues expanding its scope and raising awareness about the importance of community-centered clinical research, the Patient Advisory Board members will offer key patient insights that are an invaluable resource to the delivery and advancement of clinical trials.
By Walgreens · Via Business Wire · December 13, 2024
Nearly a Third of Americans Worry About Missing a Holiday Event Due to Illness
Staying healthy during the holiday season isn’t an easy task. According to a recent survey from Walgreens, 47 percent of Americans have missed a holiday event in recent years due to unexpected illness and nearly one in three are worried about it happening again this year.
By Walgreens · Via Business Wire · December 12, 2024
Soda Health Adds Walgreens to Network of Integrated Retailers, Serving More than 100 Million Medicare Advantage and Medicaid Members
DEERFIELD, Ill. and BENTONVILLE, Ark., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Soda Health today announced the expansion of the Soda Health Smart Benefits program to include Walgreens, the leading integrated independent retail pharmacy and healthcare provider, in the company’s network of integrated retailers. The program, which allows recipients to receive personalized health and wellness benefits, is available to participating Medicare Advantage, Medicaid and employer benefits programs, as well as other public organizations.
By Soda Health · Via GlobeNewswire · December 10, 2024
Walgreens Boots Alliance Schedules Fiscal 2025 First Quarter Earnings Announcement for January 9
Walgreens Boots Alliance, Inc. (Nasdaq: WBA) will release its fiscal year 2025 first quarter results at 7 a.m. ET on Thursday, January 9, followed by a one-hour conference call with WBA management beginning at 8:30 a.m. ET.
By Walgreens Boots Alliance · Via Business Wire · December 6, 2024
Walgreens Boots Alliance Provides Notice of Pending and Proposed Settlement of Shareholder Derivative Action
Walgreens Boots (NASDAQWBA):
By Walgreens Boots · Via Business Wire · November 29, 2024
Global Recognition Awards Appoints Sanjay Bauskar as Judge
Sanjay Bauskar, a senior database architect with 23 years of experience in cloud computing and enterprise systems, joins the Global Recognition Awards judging panel, bringing expertise from Fortune 500 implementations and published research.
Via Press Release Distribution Service · November 27, 2024
Empower 2024 Delivers Groundbreaking Insights and Innovation to Achieve Data-Driven Healthcare
Inovalon Unveils New Research, Products, and Solutions to Tackle Healthcare’s Most Complex Challenges
By Inovalon Holdings, Inc. · Via GlobeNewswire · November 4, 2024
Walgreens Offers No-Cost Rapid COVID-19 and Flu Testing to Military Veterans
To help improve access to fast, reliable testing for veterans, Walgreens is now offering no-cost testing through a partnership with the Centers for Disease Control and Prevention (CDC).* Eligible veterans will be able to receive an easy combination test for COVID-19 and influenza at Walgreens locations across the country throughout this year’s respiratory season, with results in 30 minutes or less.** No-cost COVID-19 and flu testing will also continue to be available at Walgreens for uninsured patients via the CDC program.
By Walgreens · Via Business Wire · October 31, 2024
Walgreens Launches Annual Flu Index to Help Communities Track Flu Activity
Walgreens has launched the 2024-2025 Walgreens Flu Index, an online, interactive tool that tracks weekly flu activity based on flu-related prescription data across the company’s community pharmacy locations nationwide.
By Walgreens · Via Business Wire · October 30, 2024
Walgreens Honors Veterans, Active Duty Military and Families with Veterans Day Discount Friday, November 8 through Monday, November 11
To celebrate the service and commitment of the nation’s military and honor those who serve the country, Walgreens is offering a four-day in-store discount to all veterans, active-duty military personnel and their family members.
By Walgreens · Via Business Wire · October 29, 2024
Walgreens Boots Alliance Declares Quarterly Dividend
Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that its board of directors has declared a quarterly dividend of 25 cents per share, unchanged from the previous quarter. The dividend is payable on Dec. 12, 2024, to stockholders of record as of Nov. 18, 2024.
By Walgreens Boots Alliance · Via Business Wire · October 24, 2024
Walgreens Collects More than 6-Million Pounds of Unused Prescription Medication, Seeks the Public’s Help for National Drug Takeback Day
Walgreens is calling on the public to help in the fight against prescription drug abuse by taking part in National Prescription Drug Takeback Day on Saturday, October 26th, 2024. Twice a year, drug takeback days are reserved for the safe disposal of unwanted, unused, or expired medications. Walgreens has more than 1,550 kiosks across 46 states and Washington, D.C. These kiosks are a convenient way to ensure medications are not accidentally or intentionally misused.
By Walgreens · Via Business Wire · October 22, 2024
Walgreens Stock Rally: 4 Reasons WBA Could Be a Strong Buy
Walgreens Boots Alliance (WBA) is down 60% from its 52-week high, but improving earnings, cost cuts, and a 9.27% dividend yield signal potential recovery.
Via MarketBeat · October 22, 2024
Realty Income: A Dividend Powerhouse With Growth Potential
Realty Income's consistent dividend payments and strategic growth potential make it an attractive investment for income-focused and growth-oriented investors.
Via MarketBeat · October 16, 2024